Individuals’ metabolomic marker profiles may predict the onset of inflammatory bowel disease a decade in advance, underlining ...

Spyre Therapeutics' innovative combination therapy approach targets multiple inflammatory pathways. Learn why SYRE stock is a Buy.

Crohn's disease, a debilitating inflammatory bowel disease, has many known contributing factors, including bacterial changes in the microbiome that foster an inflammatory environment.

The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...

Drinking two small glasses of cherry juice a day may reduce gut inflammation and boost quality of life in bowel disease ...

A new study published in BMC Gastroenterology identified that patients with inflammatory bowel disease (IBD), such as Crohn's ...

Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...

A young woman had to relearn how to walk and talk after what she initially believed was a severe headache turned out to be a ...

A CT scan revealed that Phoebe had suffered a stroke, leaving her bedridden and reliant on tube feeding for four days. Tests ...

A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...

Cases of early onset colorectal cancer, occurring in people between the ages of 20 and 45, have increased in recent decades.